Announce Date | 07/30/2025 |
EPS Normalized Actual | $1.06 (Beat by $0.08) |
EPS GAAP Actual | $1.06 (Beat by $0.08) |
Revenue Actual | $0.6875B |
Revenue Surprise | Beat by $687.5M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.41604 |
EPS GAAP Estimate | $1.41604 |
Revenue Estimate | $0.60964276B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 13.06818 | 10.05 | 12.09895 | 14.02713 | 10 |
Dec 2028 | 12.141 | 10.82 | 11.13499 | 15.09926 | 8 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.09 | -0.25649 | 0.6875B | 14.15% | 86.91M |
FQ1 2025 (Mar 2025) | 0.08 | -0.95403 | 0.5726B | 10.01% | 13.63M |
FQ4 2024 (Dec 2024) | 1.03 | 1.03 | 0.6277B | 17.92% | 627.7M |
FQ3 2024 (Sep 2024) | 1.28 | 1.28 | 0.6221B | 19.82% | 622.1M |
FQ2 2024 (Jun 2024) | 0.64 | 0.64 | 0.5902B | 23.3% | 590.2M |
FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 0.5153B | 18.42% | 515.3M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0.5152B | 20.03% | 515.2M |
FQ3 2023 (Sep 2023) | 0.85 | 0.85 | 0.4988B | 22.23% | 498.8M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.41604
Consensus Revenue Estimates
0.60964276B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.708 | -- | 1.614 | 1.82718 | 6 |
FQ3 2027 (Sep 2027) | 1.6533 | -- | 1.6533 | 1.6533 | 6 |
FQ2 2027 (Jun 2027) | 1.5986 | -- | 1.5986 | 1.5986 | 6 |
FQ1 2027 (Mar 2027) | 1.3837 | -- | 1.30755 | 1.48025 | 9 |
FQ4 2026 (Dec 2026) | 3.175 | -- | 2.90928 | 3.37491 | 8 |
FQ3 2026 (Sep 2026) | 2.973 | -- | 2.72419 | 3.16019 | 6 |
FQ2 2026 (Jun 2026) | 2.8205 | 61.35 | 2.58445 | 2.99809 | 10 |
FQ1 2026 (Mar 2026) | 2.5277 | 96.84 | 2.31615 | 2.68685 | 6 |
FQ4 2025 (Oct 2025) | 1.6096 | 36.01 | 1.53815 | 1.75546 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.83B | -- | 0.79B | 0.87B | 12 |
FQ3 2027 (Sep 2027) | 0.69B | -- | 0.69B | 0.69B | 12 |
FQ2 2027 (Jun 2027) | 0.68B | -- | 0.68B | 0.68B | 14 |
FQ1 2027 (Mar 2027) | 0.78B | -- | 0.75B | 0.83B | 14 |
FQ4 2026 (Dec 2026) | 0.89B | -- | 0.83B | 0.94B | 8 |
FQ3 2026 (Sep 2026) | 0.86B | -- | 0.81B | 0.9B | 8 |
FQ2 2026 (Jun 2026) | 0.83B | 17.15 | 0.78B | 0.87B | 12 |
FQ1 2026 (Mar 2026) | 0.79B | 27.71 | 0.74B | 0.83B | 8 |
FQ4 2025 (Oct 2025) | 0.64B | 1.64 | 0.62B | 0.68B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.34649 | 1.09 | -0.25649 | -23.53% |
FQ1 2025 (Mar 2025) | 1.03403 | 0.08 | -0.95403 | -1192.54% |
FQ4 2024 (Dec 2024) | 1.03 | 1.03 | 100% | |
FQ3 2024 (Sep 2024) | 1.28 | 1.28 | 100% | |
FQ2 2024 (Jun 2024) | 0.64 | 0.64 | 100% | |
FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0.85 | 0.85 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.6B | $0.69B | $86.91M | 12.64% |
FQ1 2025 (Mar 2025) | $0.56B | $0.57B | $13.63M | 2.38% |
FQ4 2024 (Dec 2024) | $0B | $0.63B | $627.7M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.62B | $622.1M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.59B | $590.2M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.52B | $515.3M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.52B | $515.2M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.5B | $498.8M | 100% |